-
Mashup Score: 13The cutting-edge way doctors are using AI to save lives - 2 month(s) ago
Doctors at the Mayo Clinic in Minnesota are using artificial intelligence and pairing it with something similar to a traditional electrocardiogram, giving them the ability to screen for deadly heart conditions. NBC’s Morgan Radford reports for TODAY.
Source: www.today.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 20ECG Interpretation in Toxicology | ECG Cases | EM Cases - 4 month(s) ago
A systematic approach to ECG interpretation can identify toxic ECG changes and help guide patient care on EM Cases’ ECG Cases blog
Source: emergencymedicinecases.comCategories: General Medicine News, General HCPsTweet-
Use the HEARTS mnemonic to figure out what's going on in this case w/Dr. Jessie McLaren in our latest post on #ECG interpretation in Toxicology here: https://t.co/LO57D576Kj đ«Heart rate/rhythm âĄElectrical conduction/QRS đ§Axis đR-wave progression đȘ«Voltage Size đST/T Segment https://t.co/1vRZ1ktM4O
-
-
Mashup Score: 5ACC CardiaCast: Courtside with the Chair - Pitfalls and Solutions to Consider When Screening Athletes, Part 2 - American College of Cardiology - 5 month(s) ago
âCourtside with the Chairâ is a new series within CardiaCast presented by the Sports and Exercise Cardiology Member Section covering topics within the field of sports and exercise cardiology. In Part 2 of this episode, Dr. Jonathan Kim is joined by Drs. Sawalla Guseh, Rachel Lampert, and Dermot Phelan who continue the discussion of pitfalls in various cardiac screening strategies employed for athletes, including history and physical, electrocardiogram and other imaging modalities, and approaches to
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet-
Listen to a new episode of Courtside w/ the Chair where an expert panel of cardiologists discuss pitfalls in various cardiac screening strategies employed for athletes, including history & physical, #ECG & more, and approaches to mitigate these issues. https://t.co/zyK2Sdxcq5 https://t.co/dt0bHY6Q1Y
-
-
Mashup Score: 0Cardiomatics Obtains the Worldâs 1st MDR Certification for AI-based ECG Interpretation and Implements new Functionalities - 6 month(s) ago
October 13, 2023 â The newly MDR-certified Cardiomatics solution is accurate, fast and easy-to-use AI-based standalone software for ECG analysis. The Cardiomatics ECG interpretation platform is used by more than 200 clinics and 1,000 medical professionals. The platform has shown how clinical-grade and validated AI can be used to automate the ECG analysis workflow allowing medical professionals to save hours per day and focus on clinical decisions. The Medical Device Regulation (MDR) is the EU’s most recent and comprehensive framework for the approval of medical devices. These stricter requirements were introduced to improve the quality, safety and reliability of medical devices, strengthen transparency and information for patients and enhance vigilance and market surveillance. “Cardiomatics makes diagnostics much faster and more productive. This innovative AI-based ECG interpretation platform is MDR-certified now – we can be sure of quality, precision, and commitment to patient well-
Source: www.dicardiology.comCategories: Cardiologists, Latest HeadlinesTweet-
@DAICeditor @cardiomatics The #software updates introduce fast-track analysis and a user-friendly layout for quicker review of #ECG findings, enhancing efficiency for #medical professionals: https://t.co/ysULojQ3tu
-
-
Mashup Score: 0FDA clears AI model for detecting signs of heart failure in ECGs - 7 month(s) ago
The advanced AI model, developed by Anumana with help from Mayo Clinic, could provide value as a screening tool for heart failure.
Source: cardiovascularbusiness.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
ICYMI: FDA clears #AI model for detecting signs of heart failure in ECGs @MayoClinic @_nference @anumanainc @Mayoplatform #cardiology #cardiotwitter #ECG https://t.co/iR4lq1yHB7
-
-
Mashup Score: 9FDA clears AI model for detecting signs of heart failure in ECGs - 7 month(s) ago
The advanced AI model, developed by Anumana with help from Mayo Clinic, could provide value as a screening tool for heart failure.
Source: cardiovascularbusiness.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
FDA clears #AI model for detecting signs of heart failure in ECGs @MayoClinic @_nference @anumanainc @Mayoplatform #cardiology #cardiotwitter #ECG https://t.co/GJobhuBGtV
-
-
Mashup Score: 19Performance of Single-Lead Handheld Electrocardiograms for Atrial Fibrillation Screening in Primary Care: The VITAL-AF Trial - 7 month(s) ago
Abstract Background Handheld single-lead electrocardiographic (1L ECG) devices are increasingly used for atrial fibrillation (AF) screening, but their real-world performance is not well understood….
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet-
In an older primary care population undergoing #AFib screening with handheld 1L ECGs, automated algorithm interpretations were sufficiently accurate to exclude the presence of AF but not to establish an AF diagnosis. https://t.co/CClV5G6Hfp #JACCAdvances #ECG #CardioTwitter https://t.co/h5Wa9XPFVQ
-
-
Mashup Score: 0SmartCardia Receives FDA Clearance for its 14-Day 7-Lead ECG Real-Time Patch and Cloud Platform - 7 month(s) ago
September 19, 2023 â SmartCardia has received FDA clearance for its 7-lead real-time ECG monitoring patch and cloud platform. SmartCardia’s 7L patch is easy-to-wear, cable-free, waterproof and can be used for continuous monitoring for up to 14 days. “SmartCardia’s 7L patch and cloud platform is a single solution that covers the entire spectrum of cardiac monitoring including screening, post-operative follow-up, and remote patient monitoring. It has been designed ground-up to meet the stringent requirements of these different applications”, said Srinivasan Murali, co-founder and CEO of SmartCardia. One of the major limitations of cardiac patches in the market is the lack of multiple, reciprocal leads that enable accurate arrhythmia detection. SmartCardia’s 7L patch provides excellent P and QRS waves, unprecedented signal quality and allows for accurate detection of arrhythmias thanks to its 7 ECG leads. According to the CTO, Francisco Rincon: “100% of the ECG data, not just events, i
Source: www.dicardiology.comCategories: Cardiologists, Latest HeadlinesTweet-
@DAICeditor @smartcardia #SmartCardia has received FDA clearance for its 7-lead real-time #ECG #monitoring_patch and #cloud platform: https://t.co/K4HyAZYDwo
-
-
Mashup Score: 0FDA clears 14-day ECG patch, cloud platform from SmartCardia - 7 month(s) ago
SmartCardia announced today that it received FDA clearance for its seven-lead, real-time ECG monitoring patch and cloud platform.
Source: www.massdevice.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
#FDA clears 14-day #ECG patch, #cloud platform from @SmartCardia | #cardiac https://t.co/KROr3Ryxau https://t.co/1JzuiHX4KI
-
-
Mashup Score: 13Postdevelopment Performance and Validation of the Artificial Intelligence-Enhanced Electrocardiogram for Detection of Cardiac Amyloidosis: - 7 month(s) ago
Abstract Background We have previously applied artificial intelligence (AI) to an electrocardiogram (ECG) to detect cardiac amyloidosis (CA). Objectives In this validation study, the authors observ…
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet-
#AI-#ECG for detection of CA maintained overall strong performance w/ respect to age, sex, race, & amyloid subtype. âŹïž performance noted in #LBBB, LVH, & ethnically diverse populations emphasizing need for subgroup-specific validation efforts https://t.co/JnzaLTJ6Zo #JACCAdvances https://t.co/tfMtYhGxdF
-
AI supercharges the #ECG @MayoClinicCV, detecting heart disease sooner to improve outcomes for patients, @DrPaulFriedman tells @TODAYshow. https://t.co/Xo0rxLanld